Brand Recall Hub

Review Recalls in Canada

11 recalls found for Review. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

11 Review Recalls

Other
2026-07-07

TAVNEOS (avacopan) and Health Canada’s Review of Data Integrity Concerns

New safety information - Product safety

View recall details →
Other
2022-04-06

Updated safety review of breast implants underscores the continuing importance of monitoring for cancer; increased risk with highly textured (macro-textured) implants

New safety information

View recall details →
Other
2022-01-12

Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer

Product safety

View recall details →
Medical Devices Type II
2019-09-06

HFA Review (accessory of Humphrey Field Analyzer 3 (HFA3)) (2019-09-06)

Medical devices

View recall details →
Other
2019-05-28

Health Canada suspends Allergan's licences for its Biocell breast implants after safety review concludes an increased risk of cancer

Product safety

View recall details →
Other
2019-02-12

Health Canada will be updating its safety review of breast implants

Product safety

View recall details →
Other
2019-01-11

Health Canada safety review finds possible link between Fibristal and risk of liver injury

View recall details →
Other
2018-11-26

Summary Safety Review: Health Canada concludes that there are no new safety concerns with sunscreen products

View recall details →
Medical Devices Type III
2018-10-19

BD FocalPoint GS Review Station, Slide Profiler, and FocalPoint Slide Profiler (Refurbished) (2018-09-20)

Medical devices

View recall details →
Other
2018-03-15

Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids

Product safety

View recall details →
Medical Devices Type III
2018-02-01

System DI-60 Main Unit and Remote Review Software (2018-01-23)

Medical devices

View recall details →